In addition to other studies that observed hyperactivation of the PI3K/AKT pathway due to Kremen2 overexpression [10], our transcriptome sequencing results suggested that Kremen2 may also be involved in multiple oncogenic signaling pathways in NSCLC. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.